Novo Nordisk stock sinks after anti-inflammatory heart drug fails late-stage trial
The experimental anti-inflammatory drug ziltivekimab did not reduce major adverse cardiovascular events compared with a placebo in a study of more than 6,300 patients
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
How to use the AirPods Pro 3’s heart rate tracking feature
<p style="text-align:left;"><span style="color:rgb(0, 0, 0);font-family:Arial, sans-serif;">Your AirPods may soon become your most important pieces of fitness gear. One [...]
Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond D
<img src="https://media.thenextweb.com/2026/05/Novo-Nordisk.avif" width="868" height="488"><br /><p>Novo Holdings, the investment company that controls [...]
Novo Nordisk hands shelved Parkinson’s cell therapy to Zuckerberg-backed
<img src="https://media.thenextweb.com/2026/05/Novo-Nordisk.avif" width="868" height="488"><br /><p>Novo will take an equity stake in Cellular Intellige [...]
Most enterprises can't stop stage-three AI agent threats, VentureBeat
<p>A rogue AI agent at Meta <a href="https://venturebeat.com/security/meta-rogue-ai-agent-confused-deputy-iam-identity-governance-matrix">passed every identity check and still ex [...]